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Summary 
 
Background: Salsola kali is an Amaranthaceae weed with important repercussions in 
pollinosis of temperate areas. Ole e 1-like members are relevant allergens in pollen from 
different species. We aimed to characterize and produce as recombinant allergen S. kali Ole 
e 1-like protein. 
Methods: The natural allergen was purified at homogeneity after three 
chromatographic steps. Specific cDNA was sequenced and expressed in Pichia pastoris 
yeast. Structural relationships of natural and recombinant forms were carried out by 2D-
electrophoresis and spectroscopic analyses. Its immunological relevance was analyzed by 
ELISA and immunoblotting using an IgG antiserum and monoclonal antibodies specific to Ole 
e 1, as well as sera from fifty-seven allergic patients recruited from two Spanish regions 
where this pollinosis is frequent.  
Results: The purified allergen, Sal k 5, is an acidic glycoprotein of 151 amino acid 
residues and 17628 Da of molecular mass. Its amino acid sequence exhibits 68% and 32% 
of identity with the allergens of this family Che a 1 and Ole e 1, respectively. The 
recombinant protein was correctly processed and its structural and immunologic equivalence 
to the natural form was proved. A sensitization frequency up to 30% was observed in pollinic 
patients from the center and coastal east of Spain.  
Conclusions: Sal k 5 is a member of the Ole e 1-like protein family, which can be 
considered an important allergen from S. kali. Its inclusion in diagnosis protocols would allow 
accurately defining patients allergic to this pollen.  
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Introduction 
 
Soil desertification of extensive zones from the Mediterranean area is enhancing the 
incidence of certain widespread weeds of temperate areas and salt soils, such as 
Chenopodiaceae species that have been recently included within Amaranthaceae family 
[1].Sensitization to pollen from these species has constituted a severe problem in semi-
desertic countries such as Iran, Kuwait and Saudi Arabia [2,3]. The resistance to drought of 
these plants, the use of several species in hedges, ornamental decoration and irrigated 
crops, as well as its presence as contaminant weeds in culture areas such as those of olive 
trees, have made these plants important pollinosis inducers in the Mediterranean area [4-6]. 
Although Russian thistle (Salsola kali) and Lamb’s quarter (Chenopodium album) are the 
most representative pollens of the family in terms of allergenic incidence in Spain [6-9], other 
species of the Amaranthaceae family as Salsola pestifer, Amaranthus retroflexus or Salsola 
oppositifolia have been reported as allergenic species [10,11]. 
 Although these weeds have been currently considered as minor sources of allergens 
because they count for a reduced number of pollen grains, up to 30 to 40% of the sensitized 
individuals exhibiting symptoms at the end of summer in several regions of Spain are allergic 
to these aggressive pollens. Nowadays, in Spain, Salsola pollen is the third more relevant 
cause of pollinosis after olive and grasses [6], either in regions where allergy to this pollen is 
one of the major sensitization causes, as for instance Zaragoza and Murcia, or in those 
regions such as central Spain were the wild growth of this weed is concomitant to olive tree 
cultivars [4,12].  
Three allergens have been identified and characterized in C. album pollen: Che a 1, a 
member of the Ole e 1-like protein family, the profilin Che a 2 and the polcalcin Che a 3 [7]. 
Regarding S. kali allergens, Sal k 1, a pectin methylesterase, has been described so far as 
major allergen and specific marker of S. kali pollen [9], and several minor allergens reported: 
Sal k 3, a methionine synthase [13] and the profilin Sal k 4 [14,15]. In addition, sera of 
patients allergic to S. kali contain IgEs able to bind to other proteins in immunoblotting with 
high frequency such as a 19 or 25 kDa bands that are recognized by a significant number of 
patients from several Spanish populations. Considering the existence in pollens of an 
ubiquitous protein family with molecular masses of around 19 kDa, whose representative 
member is Ole e 1, the major allergen from Olea europaea pollen [16], and having into 
account that an Ole e 1-like allergen -Che a 1- has been already identified in C. album [17], 
our aim was focused on identifying and characterizing an homologous member in S. kali 
pollen with significant allergenic character. 
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This broad group of allergens has been ubiquitously detected in different plant 
species, being exclusively expressed in pollens and exceptionally in leaves such as that of 
Sambucus nigra [18]. These cysteine-rich proteins seem to play an essential biological role 
during hydration/germination and pollinic tube growth [19]. Some of these molecules Ole e 1, 
Syr v 1, Lig v 1 and Fra e 1 are major allergens in Oleaceae pollens [9,20,21]. Other 
allergens of the family belonging to taxonomically unrelated species such as Lol p 11 from 
Gramineae and Pla l 1 from Plantaginaceae have a lower allergenic incidence in the 
Mediterranean area [22,23]. Although the allergenic character is associated to this protein 
family, a non allergenic member has been recently identified in birch [24]. The fact that this 
family contains important aeroallergens with significant repercussions in allergy 
manifestations of many populations makes its identification essential for diagnostic purposes. 
In this work, we report the isolation and characterization of an allergenic Ole e 1-like 
protein from S. kali pollen, as well as the analysis of its relevance among patients allergic to 
this pollen, whose increasing allergenic relevance in South Europe make necessary its 
inclusion in the diagnosis trials. A recombinant form has been produced in P. pastoris and 
validated using the natural form, and thus, the availability of this protein would allow using it 
as a tool for diagnosis of allergic patients to this species widely distributed in semi desert 
areas.  
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Materials and methods 
 
Pollen extracts, S. kali sensitized patients’ sera and antibodies 
 
S. kali, C. album, and O. europaea protein extracts were prepared using pollen 
provided by ALK-Abelló (Madrid, Spain) as previously described [9]. Recombinant Che a 1 
and Ole e 1 allergens were purified according to [17,25]. Sal k 1 was purified according to [9] 
and Sal k 4 was obtained as reported [15]. 
Fifty-seven patients sensitized to S. kali were recruited from Murcia, a dried coastal 
region, and Zaragoza, a province from the interior of Spain, fulfilling the following criteria: 1) 
seasonal rhinitis and/or bronchial asthma from May to September, 2) a positive skin prick test 
to S. kali pollen extract and specific IgE values >0.7 kU/l measured by CAP (Pharmacia 
Biotech, Piscataway, USA), and 3) no previous S. kali immunotherapy (table S1). One non-
atopic serum was used as negative control. All patients provided informed consent. The 
Ethical Committee of the Complutense University (Madrid, Spain) approved the protocols 
used for experimental work related to the use of human sera in the study. 
Rabbit polyclonal antiserum (pAb) against the O. europaea allergen nOle e 1 was 
used [25]. The use of animals for experimental procedures was supervised for the animal 
facility of the Fundación Jiménez Díaz (Madrid, Spain). Monoclonal antibodies (mAbs) OL3 
and OL7 obtained against nOle e 1 were used in the analysis of the structural integrity of this 
protein [26]. Horseradish peroxidase-labelled goat polyclonal antibody against rabbit IgG was 
obtained from Bio-Rad (Richmond, California). Mouse monoclonal antibody against human 
IgE was kindly donated by ALK-Abelló. Horseradish peroxidase-labelled goat polyclonal 
antibody against mouse IgG was purchased from Pierce Chemical Co. (Rockford, Ill, USA). 
 
Isolation of the allergen from S. kali pollen  
 
Three chromatographic steps, -gel permeation onto a Sephacryl S-100 column in 0.2 
M ammonium bicarbonate, pH 8.0, hydrophobic chromatography on a phenyl-sepharose 
column and eluted with a reverse hydrophobicity gradient (5 to 0 M) of NaCl, and a reverse-
phase HPLC on a Nucleosil C18 column with an acetonitrile gradient (0-60%) in 0.1% 
trifluoroacetic acid - were used for the purification of the allergen from S. kali pollen.  
 
Cloning of Sal k 5  
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Total RNA from S. kali pollen was extracted as described [9]. cDNA was synthesized 
using the SMART RACE cDNA amplification kit (BD Biosciences-Clontech, Madrid, Spain). 
Specific cDNA was amplified by two rounds of PCR using four specific primers. In the first 
step two internal primers: 5’-GTNTAYTGYGAYACNTGYCG-3’ (VYCDTCR) and 5’-
RTCRTCYTCRTGRTCNCCRTC-3’ (DGDHEDD), which were designed using the peptides 
sequences in parentheses obtained from mass spectrometry analysis, were used to obtain 
the nucleotide sequence encoding a polypeptide internal fragment of 60 amino acid residues. 
Afterwards, a second round was performed with the oligonucleotides: antisense 5’-
ACCCTCCATCATGGTGCTAAC-3’ (VSTMMEGA) and sense 5’-
ATGTACACCATCAAAGTCGACGG-3’ (MYTIKVDG) primers and the UPM unspecific primer 
included in the kit to get the whole nucleotide sequence of the protein. Finally, a PCR round 
with a sense 5´-ccgctcgagaaaagaAARGGNAAYGGNGGNCAYAAYCT-3’ (KGNGGHNL) and 
an antisense 5’-ctgcggccgcTCARTTYTGNGTNACRCTNCCNGG-3’ (PGSVTQN) primers 
corresponding to the N and C-terminal ends of the mature protein. The sense and the 
antisense primers contained a XhoI and a NotI restriction site respectively (both underlined). 
The purified DNA was directly cloned into the pCR2.1 plasmid included in the TOPO TA-
cloning kit (Invitrogen, Groningen, The Netherlands), used to transform TOP10 E. coli cells 
and sequenced [27]. The DNA fragment corresponding to Sal k 5 was digested with 
XhoI/NotI restriction enzymes and subcloned into the same sites of the pPICZA plasmid 
using DH5 E. coli cells as host.  
 
Expression and isolation of recombinant Sal k 5 
 
pPICZA/Salk5 was linearized with SacI restriction enzyme, and used to 
electroporate KM71 strain of P. pastoris cells.Transformed (His+ Muts) cells were incubated 
on YPDS/zeocin at 30 ºC for 72h in buffered glycerol complex medium until colonies 
appeared. The recombinant protein was detected by SDS-PAGE in the extracellular culture 
medium and after dialysis it was purified as described previously for the natural protein from 
S. kali pollen extract.  
 
Analytical methods  
 
SDS-PAGE was performed by the method of Laemmli in 15% polyacrylamide gels in 
the absence or presence of 2-mercaptoethanol (2-ME). Gels were stained with Coomassie 
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Blue R-250 (Sigma-Aldrich, Saint Louis, USA) or transferred to nitrocellulose membranes. 
Molecular mass determinations were done with protein markers MW-SDS-70L (Sigma-
Aldrich). N-terminal Edman degradation of the protein was performed using an ABI Procise 
494 protein sequencer (Life Technologies, Carlsbad, USA). 
The concentration of the purified proteins was calculated by measuring the 
absorbance at 280 nm in a DU-7 spectrometer (Beckman, Barcelona, Spain) using the 
extinction coefficient (0.1%) of 0.474 according to ProtParam [28]. 
 
Mass spectrometry analysis 
 
Mass spectrometry (MS) analysis was carried out on a Bruker-Reflex IV Matrix-
assisted laser-desorption ionization time-of-flight mass spectrometer (Bruker-Franzen 
Analytik, Bremen, Germany). Peptide mapping fingerprinting and MS/MS sequencing 
analyses were carried out using the 4800 Plus MALDI TOF/TOF Analyzer (Applied 
Biosystems, Carlsbad, California, USA) according to previously published methods [9]. 
 
Spectroscopic characterization 
 
Circular dichroism (CD) spectra were obtained in the far-UV (190-240 nm) on a Jasco 
J-715 spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan) [29]. Protein 
concentration was 0.20-0.25 mg/mL in 50 mM ammonium bicarbonate, pH 8.0. Mean residue 
mass ellipticities were calculated based on 113.26 as the average molecular mass/residue, 
obtained from the amino acid containing of these proteins, and expressed in terms of  
(degree x cm2 x dmol-1). CDNN CD spectra deconvolution software (Applied Photophysics, 
Leatherhead, UK) was used to deconvolute the CD spectra recorded. 
 
Carbohydrate detection and deglycosylation treatment 
 
Carbohydrate detection on protein after SDS-PAGE transferred to nitrocellulose 
membranes was performed by using a biotinylated concanavalin A (Con A) lectin solution 
[30] followed by horseradish peroxidase-labelled streptavidin diluted 1:5000. The staining 
was developed with 0.05% diaminobenzidine/0.03% of 30% H2O2 in 0.5 M NaCl, 50 mM Tris, 
pH 7.5 reaction buffer. Enzymatic deglycosylation was performed with PNGase F 
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endoglycosidase (Boehringer, Mannheim, Germany) as described [30]. nOle e 1 glycosylated 
and rSal k 4 non-glycosylated protein allergens were used as controls. 
 
2D-electrophoretic analysis 
 
2D-electrophoresis was developed in a PROTEAN IEF Cell (Bio-Rad). Isolectric focusing 
was achieved under reducing conditions in the presence of 3 mM tributylphosphine by using 
7 cm length, pH 3-10 linear ReadyStrip IPG gels (Bio-Rad). After isoelectrofocusing, proteins 
were separated by SDS-PAGE in 15% polyacrylamide gels under reducing conditions in the 
presence of,50 mM dithiothreitol and 3.7% iodoacetamide. 2D-gels were alternatively stained 
with silver reagent or transferred to nitrocellulose membranes.  
 
Immunologic analysis  
 
Immunodetection on membranes was achieved by using two Ole e 1-specific mAbs (diluted 
1:5000), a pAb raised against nOle e 1 (diluted 1:5000), individual sera or a pool of sera from 
patients sensitized to S. kali pollen (diluted 1:10) as described [15]. The IgG binding was 
alternatively detected with a horseradish peroxidase-labelled goat anti-rabbit IgG diluted 
1:3000 (Bio-Rad), or a horseradish peroxidase-labelled goat anti-mouse IgG diluted 1:5000 
(Pierce Chemical Co.), and the binding of human IgE was detected with a mouse anti-human 
IgE antibody diluted 1:5000 (ALK-Abelló) followed by horseradish peroxidase-labelled goat 
anti-mouse IgG (diluted 1:5000) [9]. For immunoblotting inhibition assays, 0.5 g of purified 
protein or 50 µg of pollen extract were incubated with a pool of sera (diluted 1:10) previously 
incubated with 500 g of pollen extracts from S. kali, C. album and O. europaea, or 5 g of 
purified proteins. The signal was detected using ECL Western blotting reagent (Amersham 
Biosciences, Barcelona, Spain). 
IgE-binding quantification was performed by ELISA in microtiter plates coated with 
100 ng/well of protein [31]. Plates were incubated with allergic sera (diluted 1:10). The 
binding of human IgE was detected as above. IgG-binding by ELISA was detected with 
monoclonal antibodies against Ole e 1 followed by a horseradish peroxidase-labelled goat 
anti-mouse IgG (diluted 1:5000) or, alternatively, with a polyclonal antiserum against Ole e 1 
followed by a horseradish peroxidase-labelled goat anti-rabbit IgG (diluted 1:3000). The 
reaction was developed with o-phenylenediamine and the optical density (OD) measured at 
492 nm. The OD values under 0.1 were considered negative. 
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For ELISA inhibition assays the plates coated with 100 ng of purified protein were 
incubated with a pool of sera (diluted 1:10) previously incubated with different concentrations 
of purified allergens or C. album, S. kali and O. europaea pollen extracts as inhibitors, and 
the signal was developed as above. 
Serum from a non-atopic individual was used as negative control in the experiments.  
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Results 
 
Identification of a 19 kDa protein band with IgE-binding reactivity  
 
Twenty-eight patients allergic to S. kali pollen from Murcia and twenty-nine from 
Zaragoza were recruited to study the allergenic profile of S. kali protein extract (fig. 1a). 
Immunoblots obtained with individual sera showed protein bands from 10 to 70 kDa. A high 
number of sera recognized a band with a molecular mass of approximately 40 kDa, mostly 
corresponding to the pectin methylesterase allergen Sal k 1 [9]. In addition, other IgE-
reactive proteins with apparent sizes of 13-15, 19 and 25-27 kDa were observed.  
A protein band of 19 kDa was recognized by 14 sera (4, 5, 11, 19, 21, 22, 23 in the 
upper panel and 2, 6, 9, 11, 15, 26, 27 in the bottom panel). The molecular mass fitted well to 
those of Ole e 1-like protein family. The putative presence of a homologue in S. kali pollen 
was analyzed by immunostaining of the S. kali extract under reducing conditions with an 
antibody raised against Ole e 1 on a 2D-electrophoresis (fig. 1b). A set of IgG-binding spots 
confirmed this protein as Ole e 1-homologue and showed the polymorphic character of this 
protein. To determine if this protein has any IgE cross-reactivity to Ole e 1-like proteins and 
considering the cross-reactivity is restricted to the phylogenetic-related species, inhibition 
assays were performed with Che a 1, an Amaranthaceae member of this family, and Ole e 1, 
an Oleaceae allergen using a pool of the above mentioned sera (fig. 1c). The abolishment of 
80% of the IgE-binding signal with Che a 1 was observed after quantifying the bands of the 
blot by densitometry, indicating that this protein share IgE epitopes with its Ole e 1-like 
counterpart Che a 1.  
 
Isolation and molecular characterization of the nSal k 5 allergen 
 
Three chromatographic steps, one gel permeation step by Sephacryl S-100, one 
hydrophobicity separation in phenyl-sepharose column and one reverse phase HPLC were 
carried out to purify the protein at homogeneity. A profile of the last chromatographic step is 
shown (fig. 2a). MS analysis rendered a broad peak with a maximum at 17628 Da (fig. 2a 
inset). The protein migrated as a single band of 19 kDa after SDS-PAGE analysis and the 
glycosylated character was assessed by Con A lectin staining (fig. 2b). This allergen was 
named Sal k 5 following the criteria of the Allergy Nomenclature Subcommittee of the 
Immunological Societies.  
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The IgG-binding ability of Sal k 5 using Ole e 1-specific pAb and two mAbs (OL3 and 
OL7) antisera, as well as a pool of sera were assayed by immunoblotting (fig. 2c). From the 
mAbs tested, only OL3 directed against a continuous epitope was able to recognize the 
protein under reducing conditions. On the other hand the IgG binding from pAb was visible 
under non-reducing conditions and the signal was more intense when 2-ME was added. 
When a pool of sera from patients sensitized to S. kali pollen was used, a marked decrease 
of the IgE-binding signal was observed in the presence of 2-ME. Therefore, the disruption of 
the disulphide bonds seems to affect in a different manner the IgE binding than the IgG 
reactivity of Sal k 5. 
The pattern of spots of the purified protein obtained after 2D-electrophoretic analysis 
and immunostaining with the pAb (data not shown) was equivalent than that obtained with 
the S. kali extract (fig. 1b). On the other hand, Edman degradation of purified Sal k 5 
rendered a single N-terminal sequence of KGN. The peptide mass fingerprinting and MS/MS 
sequencing analyses obtained by proteomic analysis of purified Sal k 5 leaded to sequences 
VYCDTCR, TMMEGATVSIKCR, VDGDHEDDLCKLVLVK and ANALGFLK. The alignment of 
these sequences with proteins included in the GenBankTM/EMBL data base revealed 
homology with members of the Ole e 1-like protein family and especially to Che a 1.  
 
Immunological properties of nSal k 5 in comparison to Ole e 1-like homologues  
 
To assess the cross-reactivity degree with Ole e 1-like allergens belonging to 
phylogenetically related or unrelated families, an immunoblotting inhibition analysis of the IgE 
binding to purified nSal k 5 was carried out using the same pool of allergic patients’ sera and 
Che a 1 and Ole e 1 allergens, from Amaranthaceae and Oleaceae families, respectively. An 
almost complete inhibition of the IgE binding was observed with 5 g of the Amaranthaceae 
allergens, either Sal k 5 (100%) or Che a 1 (95%). Using 500 g of total protein of the 
respective pollen extracts, an inhibition of 80% and 100% was obtained with C. album and S. 
kali, respectively (fig. 3a). Lack of inhibition was observed when the olive pollen extract and 
Ole e 1 were used as inhibitors. These results were further confirmed by ELISA inhibition 
using the same proteins and extracts as inhibitors (fig. 3a). No significant correlation was 
observed between the individual IgE-response to Sal k 5 and Ole e 1 (0.0002) with the 57 
sensitized patients to S. kali pollen. However, Sal k 5 and Che a 1 showed a correlation of 
0.8555, assessing the high cross-reactivity between the Ole e 1-like allergens of the 
Amaranthaceae family (fig. 3b, c). 
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PCR cloning and sequence analysis 
 
cDNA was synthesized from total RNA from S. kali pollen and used as template for 
amplification of Sal k 5 by PCR using oligonucleotides designed from internal peptide 
sequences derived from the peptide fingerprinting analysis of the natural allergen. Two 
overlapping fragments corresponding to the 5’ and 3’ ends were used to get Sal k 5-
nucleotide sequence including the signal peptide in two rounds of PCR (fig. 4a). Finally, a 
PCR performed with primers designed from the C- and N-terminal ends of the mature protein 
rendered the whole encoding sequence of the allergen. The open reading frame of this 
protein contains 176 amino acids including a signal peptide of 25 residues according to the 
N-terminal sequence obtained by Edman degradation. The theoretical molecular mass was 
16448.6 Da and a pI of 5.02 was obtained without the signal peptide. Sal k 5 contains a 
putative N-glycosylation consensus site at position 43, being this feature associated to the 
structural relationships among members of the Ole e 1-like family from phylogenetically 
related species. The sequence identity of Sal k 5 with Che a 1 was 68%, but only 42%, 26% 
and 32% with Phl p 11, Pla l 1 and Ole e 1, respectively (fig. 4b). 
 
cDNA expression and purification of rSal k 5 
 
The cDNA encoding the mature sequence of Sal k 5 was sub-cloned into the 
pPICZA expression vector. The construction pPICZA/Salk5 was used to transform P. 
pastoris KM71 cells to produce the secreted allergen by means of the AOX1 promoter 
induction with a yield of 40 mg/liter of culture of the extracellular medium. A major band of 
approximately 21 kDa was visualized by SDS-PAGE. After dialysis of the culture medium, a 
three-step procedure, by ionic exchange (DEAE-cellulose), size exclusion (Sephadex G-75), 
and RP-HPLC chromatographies, was performed to purify the recombinant protein (fig. 5a).  
 
Validation of rSal k 5 with its natural counterpart nSal k 5 
 
Structural and immunological comparisons of nSal k 5 and rSal k 5 were carried out 
to assess the integrity of the recombinant form. To that end, CD analyses of both forms were 
performed in the far-UV. The ellipticity of nSal k 5 with rSal k 5 was almost equivalent, giving 
very similar values of secondary structure elements (fig. 5b). MS analysis of rSal k 5 
rendered a major peak of 18561.4 Da, and several minor peaks with differences of 160-162.5 
Da, which would correspond to different mannose residue content (fig. 5c). rSal k 5 was 
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treated with PNGase F endoglycosidase to assess its N-glycosylation character. Treated and 
untreated samples were subjected to SDS-PAGE (fig. 5d). No deglycosylation of the natural 
protein was achieved, which suggests the presence of fucose monosaccharides in the glycan 
structure as also occurss with Ole e 1, where fucose-containing oligosaccharide are not 
removed by PNGase F. However, a partially deglycosylated recombinant form was observed 
from a mannose-rich glycan.   
A comparative analysis of the IgG- and IgE-binding activities of rSal k 5 and nSal k 5 
was performed by immunoblotting and ELISA. IgG binding of mAb and pAb to both proteins 
were similar and therefore no significant differences could be attributed to the polymorphism 
of the natural protein (data not shown). The eighteen sera, which resulted positive to purified 
nSal k 5 were tested for IgE binding by ELISA (fig. 6a) and immunoblotting (fig. 6b) to both 
natural and recombinant proteins, showing a close correlation between both forms (r = 0.78). 
Nine sera recognized better rSal k 5 and nine nSal k 5 by ELISA. IgE binding was also 
analyzed by means of ELISA inhibition with an equivolumetric pool of 5 sera. nSal k 5 and 
rSal k 5 were coated in ELISA plates and 5 g of both allergenic variants were used as 
inhibitors (fig. 6c). The shape of the two curves was similar when rSal k 5 was coated in the 
wells, whereas rSal k 5 was not able to reach a total inhibition of the IgE-binding to nSal k 5 
coated in the wells, indicating the contribution of the specific glycosydic group of nSal k 5 to 
the IgE binding, or alternatively the absence of any polypeptide epitope in the recombinant 
form. 
 
14 
 
 
 
Discussion 
 
The geographic distribution of pollen from different species is strongly influenced by 
geo-climatic conditions and thus contributes to the sensitization profile of the allergic patients 
living in a particular area [32]. In the semi desert south-eastern areas from Spain, Salsola is 
the first cause of seasonal allergy in parallel to olive or grass pollinosis [4,6]. In central 
Spanish areas, where extensive irrigation is turning grass areas into semi desert ones, a 
significant increase in Salsola allergy concomitant to a decline in grass allergy is observed 
[4,33]. 
Three key points should be addressed to highlight the relevance of Salsola pollinosis: 
i) their resistance to drought in warm countries, ii) the qualitative and quantitative differences 
in the allergenic character among the Amaranthaceae species extracts, S. kali and C. album, 
although they have been indistinctly included in the diagnosis tests for many years [6], and 
iii) the overlap of the pollination season of these species with those of other allergenic 
pollens [34] that play a significant role in the sensitization of patients from these regions. 
Amaranthaceae IgE-binding profiles are complex. The immunoblotting of S. kali 
protein extracts with individual sera from patients allergic to Amaranthaceae pollens 
rendered many IgE-reactive bands, whose identities have not been completely elucidated. 
Different IgE-binding profiles were detected from individual blots of both populations used in 
this study. Patients from Zaragoza recognized a higher number and variety of IgE-reactive 
bands than those from Murcia, whereas the latest ones recognized preferentially bands of 
19, 28 and 40 kDa. The band of 40 kDa is Sal k 1, which has been considered a specific 
marker to the primary sensitization to S. kali because it has not been detected in other plants 
of the Amaranthaceae family such as C. album [9]. However, significant inter and intra-
species cross-reactivity has been attributed to different allergens already described in this 
family such as profilins -Che a 2 and Sal k 4-, or polcacins -Che a 3- [7,8,15,35].  
Ole e 1-like protein family contains numerous allergenic members belonging to very 
different pollens from weeds, grasses and trees. Biological studies pointed out to a relevant 
function in the pollen grain activity [36]. The knowledge that most of them have been 
described as allergens allows us suggesting that an intrinsic allergenicity could be associated 
to either common structural motives or to biochemical capacity. However, the recent 
characterization of a new member from birch pollen without allergenic properties seems to 
weaken this theory [24]. In this report, we have identified a new allergen from S. kali pollen 
belonging to the ubiquitous Ole e 1-like family, which can explain the IgE cross-reactivity with 
other Amaranthaceae members. 
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Interestingly, the cross-reactivity between Ole e 1-like members has been always 
associated to those phylogenetically related allergens [17,37-39]. The reason for these IgE-
binding differences is based on their amino acid sequence, which is determinant for the 
interaction between the IgE immunoglobulin and the allergen. Thus, the identities among 
Oleaceae members -Ole e 1, Lig v 1, Syr v 1, and Fra e 1- are around 85%, and among 
Amaranthaceae allergens -Che a 1 and Sal k 5- is 68%. However, a high sequence 
variability exists between Sal k 5 and the Ole e 1-like allergens from phylogenetically non 
related species -Ole e 1, Pla l 1 or Phl p 11- being 32%, 26%, and 42%, respectively the 
identity degree. These low values notably reduce the possibility of IgE cross-reactivity among 
these allergens [40]. In fact, the important amino acid sequence differences observed 
between Ole e 1 and Sal k 5 could explain the low IgG- and IgE-reactivities between these 
two allergens and the fact that epitopes hidden in the native structure of the allergen are 
exposed to the IgG binding only when the unfolding of the molecule is produced. These 
results were also observed when Ole e 1 and Che a 1 were immunologically compared [17]. 
Here, we observed similar findings pointing out to the high-cross reactivity between 
phylogenetically related allergens and an opposite situation for phylogenetically non-related 
allergens. The IgE binding to Sal k 5 using a pool of sera rendered a complete inhibition 
when Sal k 5 and S. kali extract were used as inhibitors, and a nearly complete inhibition was 
reached with Che a 1 and C. album extract. Neither Ole e 1 nor O. europaea extract were 
able to inhibit the signal.  
Finally, a prevalence of more than 30% for natural Sal k 5 purified from pollen was 
reached in the two populations of sera herein analyzed from patients allergic to S. kali 
indicating the importance of Sal k 5.    
The yeast P. pastoris has been selected as the expression system to produce rSal k 
5. Stability, glycosylation and disulphide bond formation are structural features to consider 
when choosing the expression system to produce a protein. The success of this selection is 
herein simplified by the fact that many members of this family had been efficiently produced 
in this eukaryotic system [17]. Sal k 5 was synthesized and secreted to the extracellular 
medium of the yeast cells. The recombinant protein displayed a correct folding as determined 
by spectroscopic analysis and was also glycosylated. However, the molecular mass 
difference between the natural and the recombinant protein is assumed by a bigger size of 
the oligosaccharide incorporated in the N-glycosylation consensus site of Sal k 5, which 
should be composed of a core of N-acetylglucosamine and a group of 10 manose residues 
for the higher intensity peak and 1 extra manose of 160 Da for each additional peak for rSal k 
5 (fig. 5c), in contrast to nSal k 5, where fucose monosaccharides were present in the glycan 
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structure as also occurs in Ole e 1 glycosylated molecules. However, the recombinant 
allergen with a putative rich-mannose glycan component added by the yeast is partially 
deglycosylated by the enzyme.  
The glycosylation consensus site in these proteins seems to be coincident in all 
members of the same botanical family. Thus, a common N-glycosylation consensus site at 
Asn43 or Asn39 for Sal k 5 and Che a 1, respectively, was observed. However, a different 
site for the Oleaceae proteins –at Asn110 in Ole e 1, Syr v 1, Fra e 1 and Lig v 1- or 
Gramineae – at Asn24 in Lol p 11 or Phl p 11- have been identified. Interestingly, the birch 
member of this family, which neither is glycosylated nor contains a consensus site in its 
amino acid sequence, is the only Ole e 1-like member described so far which lacks the IgE-
binding ability [24]. Other structural feature that defines this family of allergens is their 
polymorphism,  which was also observed for Sal k 5 by 2D-PAGE, although significantly 
lower than that observed for Ole e 1 with more than 10 different isoforms sequences 
identified [41]. 
An essential requisite to include a recombinant allergen in a diagnosis protocol is its 
accurate validation of structural and immunologic parameters, mainly its IgE-binding 
capacity, and taking as reference the natural molecule. However, in most cases this 
comparison is exclusively made using the complete pollen extract where the natural allergen 
is expressed but in so low amounts that its isolation is a hard task. Herein, the availability of 
both forms of Sal k 5 allowed us accurately performing these analyses. The spectroscopic 
data as well as the immunologic inhibition assays confirmed the integrity of the recombinant 
protein and the presence of most of the B cell epitopes. The lack of a total inhibition of the 
IgE binding to nSal k 5 using rSal k 5 as inhibitor suggests a possible involvement of the 
glycan moiety in the IgE reactivity since a different carbohydrate component is incorporated 
in the N-glycosylation site by the yeast. Other possibility could be the absence of critical 
residues within the B epitopes in the recombinant isoform.  
In summary, according to previous and here presented results, S. kali pollen extract 
seems to be enough for the diagnosis and treatment of most representative Amaranthaceae 
pollen allergies, since it contains a specific and major allergen (Sal k 1) and is able to inhibit 
the IgE binding of all the other already known allergens from C. album pollen. Moreover, the 
availability of Sal k 5, together with Sal k 1, and panallergens Sal k 4 and polcalcin as 
molecular tools to establish a diagnostic algorithm, could allow to stratify patients depending 
on their sensitization: Sal k 1 as marker of allergy to S. kali pollen, Sal k 5 as index to 
Amaranthaceae sensitization, and finally Sal k 4 and polcalcin as markers of 
polysensitization. Furthermore, the correlation between the increase of this pollinosis and the 
17 
 
 
 
desertization of the soil as well as the relevance of this new member of Ole e 1-like allergen 
from S. kali makes Sal k 5, and the other allergens of S. kali pollen suitable candidates to 
optimize diagnosis protocols. 
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Legend to the Figures 
 
Fig.1. Identification of a 19 kDa protein in S. kali pollen protein extract as an 
allergenic molecule belonging to the Ole e 1-like family. (a) Analysis of the IgE-binding from 
individual allergic patients to S. kali pollen extract from two Spanish populations (Zaragoza, 
n=29 and Murcia, n=28). (b) Silver staining of the protein extract (100 g of total protein) after 
2D-electrophoresis, and immunoblotting with Ole e 1-specific IgG after transference to 
nitrocellulose membranes. (c) Immunoblotting inhibition assay of the specific binding of a 
pool of sera to S. kali pollen extract using 5 µg of Che a 1 and Ole e 1 allergens as inhibitors. 
-, no inhibitor. Molecular markers are shown. 
 
Fig.2. Purification and characterization of the natural allergen nSal k 5 from S. kali. 
(a) Reverse-phase HPLC was the last step in the isolation of nSal k 5. Horizontal bar 
represents peak fractions where Sal k 5 eluted. Mass spectrometry of the purified protein is 
shown in the inset; a.u: arbitrary units. (b) Electrophoretic mobility of nSal k 5 and 
carbohydrate detection. CBS, Comassie Blue staining and Con A, concanavalin A staining. 
rSal k 4 non-glycosilated protein was used as negative control. (c) Immunostaining analysis 
under non-reducing (-) and reducing (+) conditions with 2-ME of the IgG binding by 
monoclonal OL3 (mAb) and polyclonal (pAb) antibodies raised against Ole e 1, and IgE-
binding with a pool of sera and a non-atopic control (N). Molecular markers are shown. 
 
Fig.3. IgE cross-reactivity between allergens from the Ole e 1-like family. (a) Top, 
immunoblotting inhibition assays of the IgE binding to nSal k 5 with purified proteins, or 
pollen extracts from S. kali (Salsola), C. album (Chenopod) and O. europaea (Olive). 
Molecular markers are shown. Bottom, ELISA inhibition assays of the IgE binding to nSal k 5 
with 0.5 g and 5 g of purified allergens, or 50 g and 500 g of S. kali, C. album and O. 
europaea pollen extracts. (b and c) Regression plot of the specific IgE values of the 57 
patients’ sera measured by ELISA to nSal k 5 in comparison with those of Ole e 1 or Che a 
1. Calculated correlation (r2) observed for nSal k 5 vs Ole e 1 and nSal k 5 vs Che a 1 was 
included. 
 
Fig.4. Amino acid and nucleotide sequences of Sal k 5. (a) Nucleotide sequence and 
deduced amino acid sequence of the cDNA encoding Sal k 5. Peptide sequences showing 
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homology to peptides obtained by mass spectrometry are highlighted in grey. The amino acid 
sequence in italics corresponds to the signal peptide, the arrow indicates the processing site. 
(b) Amino acid sequence alignment of Sal k 5 and other members of the Ole e 1-like family: 
Sal k 5 (GQ427676), Che a 1 (Q8LGR0), Ole e 1 (C53806), Fra e 1 (AY652744), Syr v 1 
(S43242), Lig v 1 (O82015), Pla l 1 (AJ313166), Phl p 11 (Q8H6L7). Percentages of identity 
(I%) and similarity (S%) using Sal k 5 as reference are shown. 
 
Fig.5. Molecular comparison of recombinant and natural purified Sal k 5. (a) 
Coomassie Blue staining (CBS) after SDS-PAGE. (b) Far-UV CD spectra. h: alpha helix; 
s: beta sheet; t: beta turn; np: non-periodic conformation. (c) MS of rSal k 5, a.u: arbitrary 
units. (d) Deglycosylation of both forms compared to nOle e 1 by endoglycosydase F. 
Molecular markers are shown. 
 
Fig.6. Analysis of the IgE binding to natural and recombinant Sal k 5 of 18 sera from 
allergic patients. (a) Specific IgE-binding values measured by ELISA. (b) Immunoblotting 
staining. N, a non-atopic serum was used as negative control. (c) IgE ELISA inhibition 
assays with nSal k 5 coated-wells (left panel) and rSal k 5 coated-wells (right panel), using a 
pool of sera and the same proteins as inhibitors; insets show the same inhibition experiment 
of each panel performed by immunoblotting. -, no inhibitor. 
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